Brief Profile
Dr. Kriti Hegde has completed MD (Paediatrics) from Dr. DY Patil Medical College and Hospital & Research Centre, Navi Mumbai and later pursued Fellowship of Indian Academy of Paediatrics in Paediatric Haematology and Oncology from Lokmanya Tilak Municipal and General Hospital, Sion, Mumbai. She has also been a Clinical Fellow, Paediatric Haematology-Oncology in Great Ormond Street Hospital, London. Working at prestigious and high-volume centres like LTMGH and TMH in Mumbai, she has honed her clinical and procedural skills pertaining to Paediatric Haematology-Oncology. She has a keen interest in Late Effects and has an experience in conducting late effects Clinic at TMH, Mumbai. In the 2 years of training in United Kingdom Dr. Kriti has taken part in presenting complicated cases in interdepartmental as well as national MDT. Her time at Great Ormond Street Hospital has trained her in delivering treatment to children previously deemed to have poor outcome and go above and beyond in trying to find available options especially in the day and age of targeted therapy including Immunotherapy. Her outlook towards treating cancer has broadened and taught her, her role as a clinician is to be compassionate and provide holistic care. Dr. Kriti Hegde also has a keen interest in Clinical Governance and strives to maintain high standards. She has taken part in many audits and organized various MDTs between allied teams (such as psychosocial, occupation and physiotherapy) to optimize care for children with complex needs. During undergraduate and postgraduate training, she has organized and hosted many camps, workshops, presentations and cultural activities.
Qualification
- MD (Paediatrics)
- FIAP (Paediatric Haematology-Oncology and BMT)
- Fellowship in Paediatric Haematology-Oncology (UK)
Post held in past
- Clinical Fellow, Paediatric Haematology-Oncology at Great Ormond Street Hospital, London
- Senior Resident, Paediatric Oncology at Tata Memorial Hospital & Cancer Centre, Mumbai
Fields of Expertise
- Neuro-Oncology
- Solid Tumours
- Haematology
- Allogenic and Autologous Transplant
Awards & Recognition
- 1st place in 2017 PHOCON | Treating Acquired Aplastic Anaemia in a Public Health Hospital
- 2nd place in 2017 QUARTERLY Mumbai Haematology Group | Refractory AIHA in Thalassemia Intermedia: Thalidomide as a rescue
Professional Memberships & Certifications
- GMC, United Kingdom
- Member of Paediatric Haematology and Oncology, India
- Royal College of Paediatrics, United Kingdom
- CCLG, United Kingdom
- SIOP(E)
Publications
- Durable response to mTOR inhibitor after failing Checkpoint inhibitors in Ultra-Hypermutated High grade glioma in context of CMMRD June 2022.Neuro-Oncology 24(Supplement_1) DOI:10.1093/neuonc/noac079.247
- Hepatoblastoma: Clinical profile and outcomes in children treated over a 15-year period January 2019 Paediatric Haematology Oncology Journal 4(2):S50 DOI:10.1016/j.phoj.2019.08.142
- Masquerader of Malignancy Kriti Hegde. January 2018 Paediatric Haematology Oncology Journal 3(3):S61-S62 DOI:10.1016/j.phoj.2018.11.176
- Lung Abscess in Children: Current Perspective IOSR- JDMS, Volume 14, Issue 3 Ver. I (Mar. 2015)
- Evaluation of spirometry in asthmatic children March 2017International Journal of Contemporary Paediatrics DOI:10.18203/2349-3291.ijcp20171071
Languages Spoken
English, Hindi, Marathi
